COVID-19 Cure: WHO Finally Approves Dexamethasne For Saving Lives

Spread the love

The World Health Organisation (WHO), on Wednesday approved dexamethasone as ‘cure’ drug for saving lives of critically ill coronavirus disease (COVID-19) patients. Dexamethasone is a breakthrough in the global race to discover a safe and effective drug for treatment and prevention of the disease.

The WHO welcomed the initial clinical trial results from the United Kingdom (UK) that showed dexamethasone, a corticosteroid, can be life-saving for patients who are critically ill with COVID-19.

Dexamethasone is a steroid that has been used since the 1960s to reduce inflammation in a range of conditions, including inflammatory disorders and certain cancers. It has been listed on the WHO Model List of Essential Medicines since 1977 in multiple formulations, and is currently off-patent and affordably available in most countries.

READ ALSO  Resident Doctors To Begin Nationwide Strike On Monday September 7

WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, said: “This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support.

“This is great news and I congratulate the government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this life-saving scientific breakthrough.”

The UN health agency, in a statement, said: “The researchers shared initial insights about the results of the trial with WHO, and we are looking forward to the full data analysis in the coming days. WHO will coordinate a meta-analysis to increase our overall understanding of this intervention. WHO clinical guidance will be updated to reflect how and when the drug should be used in COVID-19.”

Leave a Reply

Your email address will not be published. Required fields are marked *